id: obesity_individual_to_NEW:non_alcoholic_fatty_liver_disease
name: Obesity â†’ Non-Alcoholic Fatty Liver Disease (NAFLD)
from_node:
  node_id: obesity_individual
  node_name: Obesity
to_node:
  node_id: NEW:non_alcoholic_fatty_liver_disease
  node_name: Non-Alcoholic Fatty Liver Disease (NAFLD)
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Obesity results from chronic caloric excess and physical inactivity, leading
  to positive energy balance and increased adipose tissue accumulation'
- 'Step 2: Excess adiposity promotes metabolic dysfunction including insulin resistance,
  altered lipid metabolism, and chronic low-grade inflammation'
- 'Step 3: These metabolic disturbances lead to increased hepatic free fatty acid
  influx and de novo lipogenesis in the liver'
- 'Step 4: Excessive lipid accumulation in hepatocytes (hepatic steatosis) develops,
  defining NAFLD'
- 'Step 5: The relationship between obesity and NAFLD is further exacerbated by associated
  conditions including metabolic syndrome and type 2 diabetes'
evidence:
  quality_rating: A
  n_studies: 9
  primary_citation: 'Alex E. Henney et al. 2023. Ultra-Processed Food Intake Is Associated
    with Non-Alcoholic Fatty Liver Disease in Adults: A Systematic Review and Meta-Analysis.
    Nutrients.'
  supporting_citations: []
description: Obesity is a primary risk factor for NAFLD through multiple interconnected
  biological mechanisms. The meta-analysis confirms that overweight/obesity, along
  with metabolic syndrome and type 2 diabetes, represents a major pathway to NAFLD
  development. Chronic caloric excess and physical inactivity drive adiposity, which
  in turn promotes hepatic fat accumulation through insulin resistance, altered lipid
  metabolism, and inflammatory processes. The evidence demonstrates a dose-response
  relationship where higher levels of obesogenic dietary patterns (ultra-processed
  foods) significantly increase NAFLD risk.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 1.42
    type: relative_risk
    ci_lower: 1.16
    ci_upper: 1.75
  p_value: 0.01
  sample_size: 60961
moderators:
- name: Ultra-processed food consumption level
  direction: strengthens
  strength: strong
  description: 'Dose-response relationship observed: moderate UPF intake shows RR
    1.03 (1.00-1.07), while high UPF intake shows RR 1.42 (1.16-1.75), indicating
    greater NAFLD risk with higher consumption levels'
- name: Type 2 diabetes comorbidity
  direction: strengthens
  strength: moderate
  description: NAFLD is strongly associated with T2D, which shares common pathophysiological
    mechanisms with obesity including insulin resistance
- name: Metabolic syndrome
  direction: strengthens
  strength: moderate
  description: Metabolic syndrome components amplify the obesity-NAFLD relationship
    through compounding metabolic dysfunction
